FI103577B1 - Menetelmä, DNA ja mikro-organismi trombolyyttisen aineen valmistamiseksi - Google Patents

Menetelmä, DNA ja mikro-organismi trombolyyttisen aineen valmistamiseksi

Info

Publication number
FI103577B1
FI103577B1 FI913818A FI913818A FI103577B1 FI 103577 B1 FI103577 B1 FI 103577B1 FI 913818 A FI913818 A FI 913818A FI 913818 A FI913818 A FI 913818A FI 103577 B1 FI103577 B1 FI 103577B1
Authority
FI
Finland
Prior art keywords
microorganism
dna
thrombolytic substance
producing
producing thrombolytic
Prior art date
Application number
FI913818A
Other languages
English (en)
Swedish (sv)
Other versions
FI103577B (fi
FI913818A0 (fi
Inventor
Bertholf Baldus
Peter Donner
Wolf-Dieter Schleuning
Alejandro Alagon
Werner Boidol
Joern Reiner Kraetzschmar
Bernard Jacques Haendler
Gernot Langer
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3904580A external-priority patent/DE3904580A1/de
Priority claimed from DE19893917949 external-priority patent/DE3917949A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI913818A0 publication Critical patent/FI913818A0/fi
Application granted granted Critical
Publication of FI103577B publication Critical patent/FI103577B/fi
Publication of FI103577B1 publication Critical patent/FI103577B1/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
FI913818A 1989-02-13 1991-08-12 Menetelmä, DNA ja mikro-organismi trombolyyttisen aineen valmistamiseksi FI103577B1 (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE3904580A DE3904580A1 (de) 1989-02-13 1989-02-13 Neues thrombolytikum
DE3904580 1989-02-13
DE3917949 1989-05-30
DE19893917949 DE3917949A1 (de) 1989-05-30 1989-05-30 Neues thrombolytikum
EP9000242 1990-02-13
PCT/EP1990/000242 WO1990009438A1 (en) 1989-02-13 1990-02-13 Novel thrombolytic

Publications (3)

Publication Number Publication Date
FI913818A0 FI913818A0 (fi) 1991-08-12
FI103577B FI103577B (fi) 1999-07-30
FI103577B1 true FI103577B1 (fi) 1999-07-30

Family

ID=25877826

Family Applications (1)

Application Number Title Priority Date Filing Date
FI913818A FI103577B1 (fi) 1989-02-13 1991-08-12 Menetelmä, DNA ja mikro-organismi trombolyyttisen aineen valmistamiseksi

Country Status (16)

Country Link
EP (1) EP0383417B1 (fi)
JP (1) JP2904918B2 (fi)
AT (1) ATE132187T1 (fi)
AU (1) AU642404B2 (fi)
BR (1) BR9007115A (fi)
CA (1) CA2046632C (fi)
DE (1) DE69024382T2 (fi)
DK (1) DK0383417T3 (fi)
ES (1) ES2085326T3 (fi)
FI (1) FI103577B1 (fi)
GR (1) GR3019328T3 (fi)
HU (1) HU217219B (fi)
IE (1) IE73229B1 (fi)
NO (1) NO308708B1 (fi)
UA (1) UA34415C2 (fi)
WO (1) WO1990009438A1 (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE69054B1 (en) * 1988-07-20 1996-08-07 Schering Ag Vampire bat salivary plasminogen activators
DE3943241A1 (de) * 1989-12-22 1991-06-27 Schering Ag Thrombolytisch wirkendes kombinationspraeparat
DE4442665A1 (de) * 1994-11-30 1996-06-05 Gruenenthal Gmbh Chimäre Proteine mit fibrinolytischen und thrombinhemmenden Eigenschaften
US5731186A (en) * 1996-02-05 1998-03-24 Schering Aktiengesellschaft Method for the production of rDSPA α1
DE10016139A1 (de) * 2000-03-27 2001-10-18 Schleuning Wolf Dieter Verfahren zur Bestimmung von löslichem Fibrin
DE10153601A1 (de) * 2001-11-02 2003-05-22 Paion Gmbh DSPA zur Behandlung von Schlaganfall
CA2522989A1 (en) * 2003-05-21 2004-12-02 Ares Trading S.A. Method of chromatographic analysis of a protein solution
DE10342518A1 (de) 2003-09-12 2005-05-12 Paion Gmbh Plasminogen-Aktivatoren mit verringerter Lysin-Bindungskapazität
GB0321997D0 (en) 2003-09-19 2003-10-22 Novartis Ag Organic compound
WO2007134617A1 (en) * 2006-05-19 2007-11-29 Paion Deutschland Gmbh Use of desmodus salivary plasminogen activator (dspa) for treating venous thromboembolism
JP5647414B2 (ja) 2006-11-17 2014-12-24 ノバルティス アーゲー Ｌｉｎｇｏ結合分子およびその医薬用使用
NZ584911A (en) 2007-11-02 2011-08-26 Novartis Ag Improved nogo-a binding molecules and pharmaceutical use thereof
EP2558580A2 (en) 2010-04-16 2013-02-20 H. Lundbeck A/S Method for the manufacture of recombinant dspa alpha1
AU2020370751A1 (en) 2019-10-24 2022-06-09 Novago Therapeutics Ag Novel anti-Nogo-A antibodies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE69054B1 (en) * 1988-07-20 1996-08-07 Schering Ag Vampire bat salivary plasminogen activators

Also Published As

Publication number Publication date
ATE132187T1 (de) 1996-01-15
NO308708B1 (no) 2000-10-16
FI103577B (fi) 1999-07-30
IE73229B1 (en) 1997-05-21
JP2904918B2 (ja) 1999-06-14
EP0383417A1 (en) 1990-08-22
UA34415C2 (uk) 2001-03-15
JPH04504799A (ja) 1992-08-27
NO913129D0 (no) 1991-08-12
BR9007115A (pt) 1991-11-26
CA2046632A1 (en) 1990-08-14
DK0383417T3 (da) 1996-05-13
HUT59724A (en) 1992-06-29
ES2085326T3 (es) 1996-06-01
IE900506L (en) 1990-08-13
AU5080790A (en) 1990-09-05
HU217219B (hu) 1999-12-28
DE69024382D1 (de) 1996-02-08
DE69024382T2 (de) 1996-08-14
FI913818A0 (fi) 1991-08-12
EP0383417B1 (en) 1995-12-27
GR3019328T3 (en) 1996-06-30
WO1990009438A1 (en) 1990-08-23
CA2046632C (en) 1999-05-11
NO913129L (no) 1991-10-11
AU642404B2 (en) 1993-10-21
HU902004D0 (en) 1991-11-28

Similar Documents

Publication Publication Date Title
FI103577B1 (fi) Menetelmä, DNA ja mikro-organismi trombolyyttisen aineen valmistamiseksi
FR2543550B1 (fr) Nouveaux derives de la tetrahydroxy-3', 4',5,7 flavone, leur methode de preparation et leur emploi therapeutique
ATE88097T1 (de) Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut.
MX172600B (es) , "procedimiento para la produccion de una proteina biologicamente activa
ATE358176T1 (de) Menschliche dnase
ATE147436T1 (de) Menschliches cytokin, interleukin-9
PH25120A (en) Replicable expression vehicle and process of preparation thereof
DE69332955T2 (de) Chimäre prokoagulierende Proteine
EP0787802A3 (fi)
ATE114169T1 (de) Morphogenetisches knochenprotein.
SE8501050D0 (sv) Biologically active fragments of human antihemophilic factor and method for preparation thereof
FR2623508B1 (fr) Proteine basique denommee phospholipase a2 isolee de venin de serpent de la famille des elapides et sa sequence en amino-acides, derives et fragments de ladite proteine, leur procede d'obtention, compositions therapeutiques et agents de diagnostic contenant ladite proteine et/ou ses derives et/ou ses fragments
ES2073425T3 (es) Una nueva glicoproteina de tipo trombomodulina susceptible de ser obtenida a partir de la orina.
DE68904462D1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten.
ATA900589A (de) Stereospezifisches verfahren fuer die herstellung von enantiomeren des 3-substituierten furo (3,4-c) pyridins, so erhaltene enantiomere oder mischungen davon sowie diese enthaltene therapeutische mittel
DE68921229D1 (de) Prozess zur Behandlung von unlöslichem heterogenem Fusionsprotein.
HUT58037A (en) Process for producing n-2,3-butadienyl tri- and tetraaminoalkane derivatives
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
DE69131253D1 (de) Zur behandlung von tumoren und hiv-infektionen nützliches pflanzliches protein
FR2631829B1 (fr) Exopolysaccharides fongiques ayant une activite immunostimulante, leur procede d'obtention et composition therapeutique les contenant
ES2077707T3 (es) Procedimiento para la inactivacion de la actividad biologica de adn.
FR2584072B1 (fr) Nouveaux derives d'isoquinoleine, leur procede de preparation, leur application en therapeutique et produits intermediaires
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.
FR2609029B1 (fr) Derives 5-aminoethyles de l'oxazolidinone-2, leur procede de preparation et leur application en therapeutique
NO900616D0 (no) Fremgangsmaate for fraksjonering av avlinger i industrieltraamateriale.

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT

Free format text: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT